help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 19, 2008
Endocrinology, doi:10.1210/en.2007-1593
A more recent version of this article appeared on October 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/10/5043    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sirianni, R.
Right arrow Articles by Pezzi, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sirianni, R.
Right arrow Articles by Pezzi, V.

Submitted on November 20, 2007
Accepted on June 6, 2008

The novel estrogen receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line

Rosa Sirianni, Adele Chimento, Carmen Ruggiero, Arianna De Luca, Rosamaria Lappano, Sebastiano Andò, Marcello Maggiolini, and Vincenzo Pezzi*

Departments of Pharmaco-Biology, and Cell Biology, University of Calabria, Arcavacata di Rende (CS), Italy

* To whom correspondence should be addressed. E-mail: v.pezzi{at}unical.it.

Many studies have indicated that estrogens could have a role in the regulation of testicular function. However, it remains uncertain whether estrogens are able to directly activate signaling pathways in male germ cells. Estrogens are synthesized by the enzyme aromatase and classically act by binding to estrogen receptors (ER){alpha} and ER{beta}. Knock-out (KO) mice for both receptor isoforms exhibit a testicular phenotype which is less severe than aromatase KO mice, suggesting the existence of an estrogen-binding receptor that may compensate for the lack of ERs. Recently, studies using estrogen-sensitive tumor cell lines have demonstrated that the G-protein-coupled receptor (GPR)-30 binds and mediates estrogen action through the activation of the EGFR/ERK/fos transduction pathway. The present study investigated the ability of 17{beta}-estradiol (E2) to activate this pathway in the mouse spermatogonial cell line (GC-1). Using the GC-1 cell line as a model system, we demonstrated that GC-1 cells express GPR30 and ER{alpha} but not ER{beta}. E2, the selective GPR30 agonist G1, and the selective ER{alpha} agonist PPT activated the rapid ERK1/2-fos signaling cascade. This response was abrogated by the EGFR inhibitor AG1478, ERK inhibitor PD98059 and ER inhibitor ICI182780, or by silencing GPR30 expression. Moreover, E2 and G1 up-regulated cyclin D1 expression and GC-1 cell proliferation. Our results indicate for the first time that estrogens, through a cross-talk between GPR30 and ER{alpha}, activate the rapid EGFR/ERK/fos pathway which in turn stimulate mouse GC-1 cell proliferation. Further studies to elucidate the involvement of rapid estrogen signaling pathways in the regulation of male fertility are warranted.


Key words: GPR30 • spermatogonia • estrogen • proliferation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society